In vitro susceptibility to rifampin and ethambutol and treatment outcome in MAC lung disease

B. Kwon (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), H. Sung (Seoul, Republic of Korea), Y. Koh (Seoul, Republic of Korea), W. Kim (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea), Y. Oh (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), C. Lim (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), S. Hong (Seoul, Republic of Korea), S. Park (Dongtan, Republic of Korea), T. Shim (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea)

Source: International Congress 2018 – The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session: The global impact of bronchiectasis and nontuberculous mycobacteria (NTM)
Session type: Poster Discussion
Number: 343
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Kwon (Seoul, Republic of Korea), Y. Chong (Seoul, Republic of Korea), M. Kim (Seoul, Republic of Korea), H. Sung (Seoul, Republic of Korea), Y. Koh (Seoul, Republic of Korea), W. Kim (Seoul, Republic of Korea), J. Song (Seoul, Republic of Korea), Y. Oh (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), J. Lee (Seoul, Republic of Korea), C. Lim (Seoul, Republic of Korea), C. Choi (Seoul, Republic of Korea), J. Huh (Seoul, Republic of Korea), S. Hong (Seoul, Republic of Korea), S. Park (Dongtan, Republic of Korea), T. Shim (Seoul, Republic of Korea), K. Jo (Seoul, Republic of Korea). In vitro susceptibility to rifampin and ethambutol and treatment outcome in MAC lung disease. 343

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: